Under a $30 million contract with the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH), three institutions have been selected to create new centers of immunology research to advance tuberculosis (TB) vaccine development.
The three recipients include the Harvard T.H. Chan School of Public Health in Boston, the Infectious Disease Research Institute of Seattle, and the Seattle Children’s Hospital. All three will be given up to seven years of support for three Immune Mechanisms of Protection Against Mycobacterium tuberculosis (Mtb) Centers, to analyze immune responses to better protect against infections. That knowledge, NIAID said, will help guide the design and creation of new and better TB vaccines.